Tmax in three treatment, three period, three sequence design [Nonparametrics]

posted by jag009  – NJ, 2019-04-12 18:19 (556 d 16:36 ago) – Posting: # 20154
Views: 1,337


» I have a question about Wilcoxon signed rank test on Tmax. In a three treatment, three period, three sequece design (two test formulations and one reference formulation with the sequences as T1-R-T2, R-T2-T1, and T2-T1-R), can we use Wilcoxon signed rank test for Tmax? If not, what can we do to statistically evaluate Tmax?

Yes there are other tests. You can't really use Wil Test because it's for 2 treatment comparisons.


Complete thread:

 Admin contact
21,165 posts in 4,411 threads, 1,474 registered users;
online 3 (1 registered, 2 guests [including 2 identified bots]).
Forum time: Tuesday 10:55 CEST (Europe/Vienna)

In theory, there is no difference between theory and practice.
But, in practice, there is.    Jan L.A. van de Snepscheut

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz